Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)
Clinical trial NCT05629208 · TERMINATED
Trial details
- NCT number
- NCT05629208
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-17
- Primary completion
- 2025-12-17
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.